Investigation The Efficacy of Manual Therapy and Exercise in Patients With Glenohumeral Arthritis
30 dicembre 2019 aggiornato da: Sibel Gayretli Atan, Istanbul University
Istanbul University, Faculty of Health Science, Division of Physiotherapy and Rehabilitation
The aim of the investigator's study is to compare the efficacy of manual therapy and exercise practices compared to exercise practice in patients with Glenohumeral Arthritis.
Thirty volunteer patients will include into the study.
Panoramica dello studio
Stato
Completato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Patients will randomly divide into two groups.
A common exercise program was applied to both groups during 15 sessions.
Manual therapy techniques will apply to the manual therapy group in addition to exercise practices.
Patients will evaluate in terms of functional status, pain, range of motion, muscle strength and health-related quality before and after 5 weeks of treatment.
Also, patient's satisfaction from treatment will evaluate at the 5th week of the treatment.
DASH and ASES forms for functional status, VAS for pain, digital goniometer for range of motion, manual muscle test for muscle strength, SF-12 for health-related quality of life, and Global Rating of Change (GRC) Scale for patient satisfaction will be used as evaluation criteria.
Tipo di studio
Interventistico
Iscrizione (Effettivo)
30
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
Istanbul
-
Bakırköy, Istanbul, Tacchino, 34180
- Istanbul University
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
40 anni e precedenti (Adulto, Adulto più anziano)
Accetta volontari sani
No
Sessi ammissibili allo studio
Tutto
Descrizione
Inclusion Criteria:
- 40 years and older patients
- To be diagnosed with GHOA by specialist physician via MRI, US or radiography and physical examination
- Unilateral shoulder pain lasting more than 2 months seen during daily living activities and at rest
Exclusion Criteria:
Patients with:
- Severe arthrosis
- Tumor
- Cervical radiculopathy
- Emotional or cognitive problems
- A neurological disease that causes muscle weakness on the shoulder
- A skin disease that may affect upper extremity assessment.
- Frozen shoulder
- Thoracic outlet syndrome
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: ''Manuel Therapy group''
This treatment group will be received Manuel Therapy techniques and exercise interventions.
|
Shoulder mobilization techniques include glenohumeral traction, anterior, posterior and inferior glide.
We will also use anterior, posterior and inferior joint stretching exercises and scapular mobilization.
Exercise interventions include range of motion exercises, stretching exercises, strengthening exercises, and pendulum exercises.
|
|
Sperimentale: ''Exercise group''
This treatment group will be received only exercise interventions.
|
Exercise interventions include range of motion exercises, stretching exercises, strengthening exercises, and pendulum exercises.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Shoulder Range of Motion (ROM)
Lasso di tempo: Evaluation will be performed first time at baseline and second time will be performed after 5 weeks rehabilitation program. After treatment "change" will be assessed.
|
The shoulder flexion, abduction, internal and external rotation ROM will be evaluated with digital goniometer while the patient will be in supine position.
|
Evaluation will be performed first time at baseline and second time will be performed after 5 weeks rehabilitation program. After treatment "change" will be assessed.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
ASES (The American Shoulder and Elbow Surgeons Standardized Shoulder Assessment) Form
Lasso di tempo: Evaluation will be performed before treatment and after 5 weeks rehabilitation program.
|
ASES is an assessment form prepared by shoulder and elbow surgeons with objective and subjective sections.
The total score is at least 0 and at most 100, and the high scores are positively correlated with the normal function.
|
Evaluation will be performed before treatment and after 5 weeks rehabilitation program.
|
|
Visual Analogue Scale (VAS)
Lasso di tempo: Evaluation will be performed before treatment and after 5 weeks rehabilitation program.
|
The levels of pain is felted at rest / activity / night will be measured using Visual Analogue Scale (VAS).Patients will be asked to evaluate their pain status with a 10-point scale and high scores are positively correlated with pain.
|
Evaluation will be performed before treatment and after 5 weeks rehabilitation program.
|
|
Manual Muscle Test
Lasso di tempo: Evaluation will be performed before treatment and after 5 weeks rehabilitation program.
|
Manual Muscle Test is a procedure for the evaluation of strength of individual muscle or muscles group, based upon the effective performance of a movement in relation to the forces of gravity or manual resistance through the available ROM.
|
Evaluation will be performed before treatment and after 5 weeks rehabilitation program.
|
|
Short Form 12 (SF-12)
Lasso di tempo: Evaluation will be performed before treatment and after 5 weeks rehabilitation program.
|
SF-12 will be used to assess physical and mental health-related quality of life.
The total score is at least 0 and at most 100, and the high scores are positively correlated with high quality of life.
|
Evaluation will be performed before treatment and after 5 weeks rehabilitation program.
|
|
Global Rating of Change (GRC) Scale
Lasso di tempo: Evaluation will be performed after 5 weeks rehabilitation program.
|
Global Rating of Change (GRC) scale will be used to assess the overall satisfaction levels of the patients.
Patients will be asked to evaluate their post-treatment status with a 5-point likert scale and high scores are positively correlated with satisfaction.
|
Evaluation will be performed after 5 weeks rehabilitation program.
|
|
The Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire
Lasso di tempo: Evaluation will be performed before treatment and after 5 weeks rehabilitation program.
|
DASH questionnaire inquires about the activities of a person in daily life, the degree of participation in recreational activities, the symptom and psychosocial state that affects their pain, emotional state and sleep quality.
The total score is at least 0 and at most 100, and the high scores are positively correlated with the increased functional impairment.
|
Evaluation will be performed before treatment and after 5 weeks rehabilitation program.
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Investigatori
- Investigatore principale: Sibel Gayretli Atan, sssibel_38@hotmail.com
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
20 maggio 2019
Completamento primario (Effettivo)
29 novembre 2019
Completamento dello studio (Effettivo)
30 dicembre 2019
Date di iscrizione allo studio
Primo inviato
11 aprile 2019
Primo inviato che soddisfa i criteri di controllo qualità
20 maggio 2019
Primo Inserito (Effettivo)
21 maggio 2019
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
2 gennaio 2020
Ultimo aggiornamento inviato che soddisfa i criteri QC
30 dicembre 2019
Ultimo verificato
1 novembre 2019
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- ''IU''
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .